Nicholas Mischel (ao6862)
University information
Contact information
Psychiatry and Behavioral Neurosciences
Assistant Professor
Director, Neuromodulation Clinic
Clinical TMS Society PULSES Training Course Faculty 2022 – Present
Clinical TMS Society Board of Directors 2024-2027
3901 Chrysler Drive
Ste. 3B
Detroit, 48201
313-577-1396
Detroit Medical Center – Sinai-Grace Hospital (Attending Psychiatrist)
Region 10 Pre-Paid Inpatient Health Plan (Medical Director)
Wayne State University, Detroit MI, B.S. Biological Sciences May 2007
Wayne State University School of Medicine, Detroit MI, MD/PhD. Medicine/Physiology May 2015
Advisor: Patrick Mueller, Ph.D. Asst. Professor of Physiology
Neural control of the circulation, Cardiovascular physiology, Neurophysiology, Cognitive neuroscience, High-tech equipment
Cardiology, Internal Medicine, Neurology, Neurosurgery
Reports of Original Work
1. Jamarie Geller, Katherine Keith, Christian Smith, Rachel Pacilio, Cynthia Arfken, Megan Oxley, Nicholas Mischel. Response to ketamine treatment for major depressive disorder not associated with number of psychiatric comorbidities. Journal of Affective Disorders Reports. 2024 January, Citations: 0
2. Soumya S Kulkarni , Nicholas A Mischel, Patrick J Mueller. Revisiting differential control of sympathetic outflow by the rostral ventrolateral medulla. Frontiers in Physiology. 2023 January. IF: 3.394 (2017), Citations: 0
3. Thomashow KM, Geller J, Froehlich A, Arfken C, Oxley M, Mischel NA. Vital Sign Changes During Intravenous Ketamine Infusions for Depression: An Exploratory Study of Prognostic Indications. The Journal of Clinical Psychopharmacology. 2022 May IF: 2.364 (2014), Citations: 4
4. Rakesh G, Mischel NA, Gunderson-Falcone G, et al. Effect of Extended Release Bupropion on Unilateral Ultrabrief Electroconvulsive Therapy Seizure Parameters in Major Depressive Disorder. The Journal of ECT. 2020 December IF: 2.28 (2018), Citations: 2
5. Rakesh GK, Mischel NA, Luber B, Keefe RS, Emory S, Lisanby SH, Szabo ST. Theta Burst Stimulation (TBS) to Modulate Cognition in Schizophrenia: A Case Series and Feasibility Study. The Journal of ECT.2019 October. IF: 2.28 (2018), Citations: 3
6. Mischel NA, Llewellyn-Smith IJ, Mueller PJ. Physical (in)activity dependent structural plasticity in bulbospinal catecholaminergic neurons of rat rostral ventrolateral medulla. Journal of Comparative Neurology 2014 February IF: 3.331 (2015), Citations: 21
7. Mueller PJ, Mischel NA. Selective enhancement of glutamate-mediated pressor responses after GABAA receptor blockade in the RVLM of sedentary versus spontaneous wheel running rats. Frontiers in Physiology 2012 November IF: 3.394 (2017), Citations: 17
8. Mischel NA, Mueller PJ. (In)activity dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity. Journal of Applied Physiology. 2011 October IF: 3.056 (2014), Citations: 42
9. P.J. Mueller, N. A. Mischel, and T.J. Scislo. Differential activation of adrenal, renal, and lumbar sympathetic nerves following stimulation of the rostral ventrolateral medulla of the rat. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology. 2011 February IF: 3.082 (2017), Citations: 40
Commentaries
1. Jamarie Geller, Katherine M Keith, Nicholas Mischel. Reply to Comments by Sadko and Jakuszkowiak: Medical Comorbidities to Depression Do Not Necessarily Limit the Effectiveness or Safety of Ketamine- Assisted Therapy. Journal of Clinical Psychopharmacology. 2023 May.
2. Mischel NA, Balon RB. Esketamine: A Drug to Treat Resistant Depression That Brings More Questions Than Answers. Journal of Clinical Psychopharmacology 2021 May-Jun IF: 3.243 (2014), Citations: 17
Case Reports
1. Anita Vaishampayan, Bassem Saad, Daniel Amarasinghe, Carly Brin, Richard Balon, Nicholas Mischel. Possible replacement of augmenting medication in treatment-resistant depression by transcranial magnetic stimulation: a case report. Brain Network and Modulation. 2022 January
2. Maximilian Carter , Kassandra Solsrud , Nicholas Mischel. Case report: Intranasal esketamine for severe major depressive disorder with psychotic features. Front Psychiatry. 2022 July Citations: 6
3. Mischel NA, Mooneyham GC, Lau C, Van Mater H, Weiner RD. Non-NMDA autoimmune encephalopathy and catatonia treated with electroconvulsive therapy: A pediatric case series and treatment guidelines. Psychosomatics. 2020 December. IF: 1.54 (2018), Citations: 1
4. Nicholas Mischel, Christian Bjerre-Real, Jonathan Komisar, Brian Ginsberg, Steven T. Szabo, and Xavier Preud’Homme. Letter to Editor. - Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series. Letter, Journal of Clinical Psychopharmacology 2018 April. IF: 3.243 (2014), Citations: 1
